A German team has identified a compound that disrupts a protein-protein interaction that localizes K-Ras to the cell membrane, thus selectively inhibiting tumor growth. The interface provides a new small molecule binding site for the handful of companies and academics working on ways to tackle the previously undruggable Ras family.